Advice on strategic development
This service provides the design of single studies as well as the development of complete preclinical programmes. Objective, design and data analysis strategies of studies are challenged and optimised in accordance with regulatory requirements.
Drug substance analyses and drug product development
Pharma Consulting Aachen offers expertise in drug product development according to up-to-date standards of process analytical technology (PAT), design of experiment (DOE) and quality by design (QbD) including the performance and evaluation of chemometric and multivariate data analyses.
Cooperation with external specialists
Drug development is a complex and multi-disciplinary challenge. Where questions arise that are not covered by the group´s expertise, Pharma Consulting Aachen is supported by a network of independent specialists covering each topic.